Global Oncology Biosimilars Market Research Report 2016

September 2016 | 118 pages | ID: G9560CE4481EN
QYResearch

Abstracts

Notes:

Production, means the output of Oncology Biosimilars

Revenue, means the sales value of Oncology Biosimilars

This report studies Oncology Biosimilars in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering

• 3SBio
• Biocon
• BioXpress Therapeutics
• Boehringer Ingelheim
• Celltrion
• Coherus Biosciences
• Dr. Reddy’s Laboratories
• Hospira
• Intas Pharmaceuticals
• Merck Serono
• Mylan
• Novartis (Sandoz)
• Pfizer
• Wockhardt

Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Oncology Biosimilars in these regions, from 2011 to 2021 (forecast), like

• North America
• Europe
• China
• Japan
• Southeast Asia
• India

Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by application, this report focuses on consumption, market share and growth rate of Oncology Biosimilars in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

Global Oncology Biosimilars Market Research Report 2016

1 ONCOLOGY BIOSIMILARS MARKET OVERVIEW

1.1 Product Overview and Scope of Oncology Biosimilars
1.2 Oncology Biosimilars Segment by Type
  1.2.1 Global Production Market Share of Oncology Biosimilars by Type in 2015
  1.2.2 Type I
  1.2.3 Type II
  1.2.4 Type III
1.3 Oncology Biosimilars Segment by Application
  1.3.1 Oncology Biosimilars Consumption Market Share by Application in 2015
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Oncology Biosimilars Market by Region
  1.4.1 North America Status and Prospect (2011-2021)
  1.4.2 Europe Status and Prospect (2011-2021)
  1.4.3 China Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
  1.4.5 Southeast Asia Status and Prospect (2011-2021)
  1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value) of Oncology Biosimilars (2011-2021)

2 GLOBAL ONCOLOGY BIOSIMILARS MARKET COMPETITION BY MANUFACTURERS

2.1 Global Oncology Biosimilars Production and Share by Manufacturers (2015 and 2016)
2.2 Global Oncology Biosimilars Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global Oncology Biosimilars Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Oncology Biosimilars Manufacturing Base Distribution, Sales Area and Product Type
2.5 Oncology Biosimilars Market Competitive Situation and Trends
  2.5.1 Oncology Biosimilars Market Concentration Rate
  2.5.2 Oncology Biosimilars Market Share of Top 3 and Top 5 Manufacturers
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL ONCOLOGY BIOSIMILARS PRODUCTION, REVENUE (VALUE) BY REGION (2011-2016)

3.1 Global Oncology Biosimilars Production and Market Share by Region (2011-2016)
3.2 Global Oncology Biosimilars Revenue (Value) and Market Share by Region (2011-2016)
3.3 Global Oncology Biosimilars Production, Revenue, Price and Gross Margin (2011-2016)
3.4 North America Oncology Biosimilars Production, Revenue, Price and Gross Margin (2011-2016)
3.5 Europe Oncology Biosimilars Production, Revenue, Price and Gross Margin (2011-2016)
3.6 China Oncology Biosimilars Production, Revenue, Price and Gross Margin (2011-2016)
3.7 Japan Oncology Biosimilars Production, Revenue, Price and Gross Margin (2011-2016)
3.8 Southeast Asia Oncology Biosimilars Production, Revenue, Price and Gross Margin (2011-2016)
3.9 India Oncology Biosimilars Production, Revenue, Price and Gross Margin (2011-2016)

4 GLOBAL ONCOLOGY BIOSIMILARS SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGIONS (2011-2016)

4.1 Global Oncology Biosimilars Consumption by Regions (2011-2016)
4.2 North America Oncology Biosimilars Production, Consumption, Export, Import by Regions (2011-2016)
4.3 Europe Oncology Biosimilars Production, Consumption, Export, Import by Regions (2011-2016)
4.4 China Oncology Biosimilars Production, Consumption, Export, Import by Regions (2011-2016)
4.5 Japan Oncology Biosimilars Production, Consumption, Export, Import by Regions (2011-2016)
4.6 Southeast Asia Oncology Biosimilars Production, Consumption, Export, Import by Regions (2011-2016)
4.7 India Oncology Biosimilars Production, Consumption, Export, Import by Regions (2011-2016)

5 GLOBAL ONCOLOGY BIOSIMILARS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 Global Oncology Biosimilars Production and Market Share by Type (2011-2016)
5.2 Global Oncology Biosimilars Revenue and Market Share by Type (2011-2016)
5.3 Global Oncology Biosimilars Price by Type (2011-2016)
5.4 Global Oncology Biosimilars Production Growth by Type (2011-2016)

6 GLOBAL ONCOLOGY BIOSIMILARS MARKET ANALYSIS BY APPLICATION

6.1 Global Oncology Biosimilars Consumption and Market Share by Application (2011-2016)
6.2 Global Oncology Biosimilars Consumption Growth Rate by Application (2011-2016)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

7 GLOBAL ONCOLOGY BIOSIMILARS MANUFACTURERS PROFILES/ANALYSIS

7.1 3SBio
  7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.1.2 Oncology Biosimilars Product Type, Application and Specification
    7.1.2.1 Type I
    7.1.2.2 Type II
  7.1.3 3SBio Oncology Biosimilars Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.1.4 Main Business/Business Overview
7.2 Biocon
  7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.2.2 Oncology Biosimilars Product Type, Application and Specification
    7.2.2.1 Type I
    7.2.2.2 Type II
  7.2.3 Biocon Oncology Biosimilars Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.2.4 Main Business/Business Overview
7.3 BioXpress Therapeutics
  7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.3.2 Oncology Biosimilars Product Type, Application and Specification
    7.3.2.1 Type I
    7.3.2.2 Type II
  7.3.3 BioXpress Therapeutics Oncology Biosimilars Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.3.4 Main Business/Business Overview
7.4 Boehringer Ingelheim
  7.4.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.4.2 Oncology Biosimilars Product Type, Application and Specification
    7.4.2.1 Type I
    7.4.2.2 Type II
  7.4.3 Boehringer Ingelheim Oncology Biosimilars Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.4.4 Main Business/Business Overview
7.5 Celltrion
  7.5.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.5.2 Oncology Biosimilars Product Type, Application and Specification
    7.5.2.1 Type I
    7.5.2.2 Type II
  7.5.3 Celltrion Oncology Biosimilars Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.5.4 Main Business/Business Overview
7.6 Coherus Biosciences
  7.6.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.6.2 Oncology Biosimilars Product Type, Application and Specification
    7.6.2.1 Type I
    7.6.2.2 Type II
  7.6.3 Coherus Biosciences Oncology Biosimilars Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.6.4 Main Business/Business Overview
7.7 Dr. Reddy’s Laboratories
  7.7.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.7.2 Oncology Biosimilars Product Type, Application and Specification
    7.7.2.1 Type I
    7.7.2.2 Type II
  7.7.3 Dr. Reddy’s Laboratories Oncology Biosimilars Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.7.4 Main Business/Business Overview
7.8 Hospira
  7.8.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.8.2 Oncology Biosimilars Product Type, Application and Specification
    7.8.2.1 Type I
    7.8.2.2 Type II
  7.8.3 Hospira Oncology Biosimilars Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.8.4 Main Business/Business Overview
7.9 Intas Pharmaceuticals
  7.9.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.9.2 Oncology Biosimilars Product Type, Application and Specification
    7.9.2.1 Type I
    7.9.2.2 Type II
  7.9.3 Intas Pharmaceuticals Oncology Biosimilars Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.9.4 Main Business/Business Overview
7.10 Merck Serono
  7.10.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.10.2 Oncology Biosimilars Product Type, Application and Specification
    7.10.2.1 Type I
    7.10.2.2 Type II
  7.10.3 Merck Serono Oncology Biosimilars Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.10.4 Main Business/Business Overview
7.11 Mylan
7.12 Novartis (Sandoz)
7.13 Pfizer
7.14 Wockhardt

8 ONCOLOGY BIOSIMILARS MANUFACTURING COST ANALYSIS

8.1 Oncology Biosimilars Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Oncology Biosimilars

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Oncology Biosimilars Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Oncology Biosimilars Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL ONCOLOGY BIOSIMILARS MARKET FORECAST (2016-2021)

12.1 Global Oncology Biosimilars Production, Revenue Forecast (2016-2021)
12.2 Global Oncology Biosimilars Production, Consumption Forecast by Regions (2016-2021)
12.3 Global Oncology Biosimilars Production Forecast by Type (2016-2021)
12.4 Global Oncology Biosimilars Consumption Forecast by Application (2016-2021)
12.5 Oncology Biosimilars Price Forecast (2016-2021)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
China Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Oncology Biosimilars
Figure Global Production Market Share of Oncology Biosimilars by Type in 2015
Figure Product Picture of Type I
Table Major Manufacturers of Type I
Figure Product Picture of Type II
Table Major Manufacturers of Type II
Figure Product Picture of Type III
Table Major Manufacturers of Type III
Table Oncology Biosimilars Consumption Market Share by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Application 3 Examples
Figure North America Oncology Biosimilars Revenue (Million USD) and Growth Rate (2011-2021)
Figure Europe Oncology Biosimilars Revenue (Million USD) and Growth Rate (2011-2021)
Figure China Oncology Biosimilars Revenue (Million USD) and Growth Rate (2011-2021)
Figure Japan Oncology Biosimilars Revenue (Million USD) and Growth Rate (2011-2021)
Figure Southeast Asia Oncology Biosimilars Revenue (Million USD) and Growth Rate (2011-2021)
Figure India Oncology Biosimilars Revenue (Million USD) and Growth Rate (2011-2021)
Figure Global Oncology Biosimilars Revenue (Million UDS) and Growth Rate (2011-2021)
Table Global Oncology Biosimilars Production of Key Manufacturers (2015 and 2016)
Table Global Oncology Biosimilars Production Share by Manufacturers (2015 and 2016)
Figure 2015 Oncology Biosimilars Production Share by Manufacturers
Figure 2016 Oncology Biosimilars Production Share by Manufacturers
Table Global Oncology Biosimilars Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global Oncology Biosimilars Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Oncology Biosimilars Revenue Share by Manufacturers
Table 2016 Global Oncology Biosimilars Revenue Share by Manufacturers
Table Global Market Oncology Biosimilars Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market Oncology Biosimilars Average Price of Key Manufacturers in 2015
Table Manufacturers Oncology Biosimilars Manufacturing Base Distribution and Sales Area
Table Manufacturers Oncology Biosimilars Product Type
Figure Oncology Biosimilars Market Share of Top 3 Manufacturers
Figure Oncology Biosimilars Market Share of Top 5 Manufacturers
Table Global Oncology Biosimilars Production by Regions (2011-2016)
Figure Global Oncology Biosimilars Production and Market Share by Regions (2011-2016)
Figure Global Oncology Biosimilars Production Market Share by Regions (2011-2016)
Figure 2015 Global Oncology Biosimilars Production Market Share by Regions
Table Global Oncology Biosimilars Revenue by Regions (2011-2016)
Table Global Oncology Biosimilars Revenue Market Share by Regions (2011-2016)
Table 2015 Global Oncology Biosimilars Revenue Market Share by Regions
Table Global Oncology Biosimilars Production, Revenue, Price and Gross Margin (2011-2016)
Table North America Oncology Biosimilars Production, Revenue, Price and Gross Margin (2011-2016)
Table Europe Oncology Biosimilars Production, Revenue, Price and Gross Margin (2011-2016)
Table China Oncology Biosimilars Production, Revenue, Price and Gross Margin (2011-2016)
Table Japan Oncology Biosimilars Production, Revenue, Price and Gross Margin (2011-2016)
Table Southeast Asia Oncology Biosimilars Production, Revenue, Price and Gross Margin (2011-2016)
Table India Oncology Biosimilars Production, Revenue, Price and Gross Margin (2011-2016)
Table Global Oncology Biosimilars Consumption Market by Regions (2011-2016)
Table Global Oncology Biosimilars Consumption Market Share by Regions (2011-2016)
Figure Global Oncology Biosimilars Consumption Market Share by Regions (2011-2016)
Figure 2015 Global Oncology Biosimilars Consumption Market Share by Regions
Table North America Oncology Biosimilars Production, Consumption, Import & Export (2011-2016)
Table Europe Oncology Biosimilars Production, Consumption, Import & Export (2011-2016)
Table China Oncology Biosimilars Production, Consumption, Import & Export (2011-2016)
Table Japan Oncology Biosimilars Production, Consumption, Import & Export (2011-2016)
Table Southeast Asia Oncology Biosimilars Production, Consumption, Import & Export (2011-2016)
Table India Oncology Biosimilars Production, Consumption, Import & Export (2011-2016)
Table Global Oncology Biosimilars Production by Type (2011-2016)
Table Global Oncology Biosimilars Production Share by Type (2011-2016)
Figure Production Market Share of Oncology Biosimilars by Type (2011-2016)
Figure 2015 Production Market Share of Oncology Biosimilars by Type
Table Global Oncology Biosimilars Revenue by Type (2011-2016)
Table Global Oncology Biosimilars Revenue Share by Type (2011-2016)
Figure Production Revenue Share of Oncology Biosimilars by Type (2011-2016)
Figure 2015 Revenue Market Share of Oncology Biosimilars by Type
Table Global Oncology Biosimilars Price by Type (2011-2016)
Figure Global Oncology Biosimilars Production Growth by Type (2011-2016)
Table Global Oncology Biosimilars Consumption by Application (2011-2016)
Table Global Oncology Biosimilars Consumption Market Share by Application (2011-2016)
Figure Global Oncology Biosimilars Consumption Market Share by Application in 2015
Table Global Oncology Biosimilars Consumption Growth Rate by Application (2011-2016)
Figure Global Oncology Biosimilars Consumption Growth Rate by Application (2011-2016)
Table 3SBio Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 3SBio Oncology Biosimilars Production, Revenue, Price and Gross Margin (2011-2016)
Figure 3SBio Oncology Biosimilars Market Share (2011-2016)
Table Biocon Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Biocon Oncology Biosimilars Production, Revenue, Price and Gross Margin (2011-2016)
Figure Biocon Oncology Biosimilars Market Share (2011-2016)
Table BioXpress Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table BioXpress Therapeutics Oncology Biosimilars Production, Revenue, Price and Gross Margin (2011-2016)
Figure BioXpress Therapeutics Oncology Biosimilars Market Share (2011-2016)
Table Boehringer Ingelheim Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Boehringer Ingelheim Oncology Biosimilars Production, Revenue, Price and Gross Margin (2011-2016)
Figure Boehringer Ingelheim Oncology Biosimilars Market Share (2011-2016)
Table Celltrion Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Celltrion Oncology Biosimilars Production, Revenue, Price and Gross Margin (2011-2016)
Figure Celltrion Oncology Biosimilars Market Share (2011-2016)
Table Coherus Biosciences Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Coherus Biosciences Oncology Biosimilars Production, Revenue, Price and Gross Margin (2011-2016)
Figure Coherus Biosciences Oncology Biosimilars Market Share (2011-2016)
Table Dr. Reddy’s Laboratories Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Dr. Reddy’s Laboratories Oncology Biosimilars Production, Revenue, Price and Gross Margin (2011-2016)
Figure Dr. Reddy’s Laboratories Oncology Biosimilars Market Share (2011-2016)
Table Hospira Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Hospira Oncology Biosimilars Production, Revenue, Price and Gross Margin (2011-2016)
Figure Hospira Oncology Biosimilars Market Share (2011-2016)
Table Intas Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Intas Pharmaceuticals Oncology Biosimilars Production, Revenue, Price and Gross Margin (2011-2016)
Figure Intas Pharmaceuticals Oncology Biosimilars Market Share (2011-2016)
Table Merck Serono Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck Serono Oncology Biosimilars Production, Revenue, Price and Gross Margin (2011-2016)
Figure Merck Serono Oncology Biosimilars Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Oncology Biosimilars
Figure Manufacturing Process Analysis of Oncology Biosimilars
Figure Oncology Biosimilars Industrial Chain Analysis
Table Raw Materials Sources of Oncology Biosimilars Major Manufacturers in 2015
Table Major Buyers of Oncology Biosimilars
Table Distributors/Traders List
Figure Global Oncology Biosimilars Production and Growth Rate Forecast (2016-2021)
Figure Global Oncology Biosimilars Revenue and Growth Rate Forecast (2016-2021)
Table Global Oncology Biosimilars Production Forecast by Regions (2016-2021)
Table Global Oncology Biosimilars Consumption Forecast by Regions (2016-2021)
Table Global Oncology Biosimilars Production Forecast by Type (2016-2021)
Table Global Oncology Biosimilars Consumption Forecast by Application (2016-2021)